Summary. The case histories of 72 subsequently treated patients -44 with acute leukemia, 10 with chronic myeloid leukemia, 16 with severe aplastic anemia and 2 with neuroblastoma -were analyzed after bone marrow transplantation (BMT) with respect to pulmonary diseases. Thirty-eight patients suffered from a total of 51 pulmonary complications, which led to death in 20. Of 13 patients, 3 died of bacterial pneumonia, all of them during granulocytopenia; 2 of 6 patients died of fungal pneumonia and 2 out of 3 of a mixed bacterialmycotic infection. Adult respiratory distress syndrome (ARDS) led to death in 2 patients. A granulocyte count under 500/gl correlated significantly (P < 0.002) with the fatal outcome of bacterial, fungal and ARDS pneumonia as well as with bronchitis. Viral pneumonia led to death in 8 of 9 patients; in each there was a significant correlation ( P < 0.05) with graft-versus-host disease (GvHD). Patients with repeated episodes of pulmonary illness had significantly more chronic GvHD (P < 0.05); several of these patients displayed a reduction in helper T cells and an increase in suppressor T cells in the peripheral blood. The natural killer (NK) * Supported in part by SFB 120, A2, B1, C1, F2
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Abbreviations: A E L = a c u t e erythroid leukemia; A H T C G = anti-human T-cell globulin; ALL = acute lymphoblastic leukemia; A M L = acute myeloid leukemia; ARDS = adult respiratory distress syndrome; A U L = a c u t e undifferentiated leukemia; B M T = b o n e marrow transplantation; CR=complete remission; CML=chronic myeloid leukemia; CMV=cytomegalo-virus; Ext.=extensive; G v H D = g r a f t versus host disease; Lim.=limited; PR=partial remission; Rel.=relapse; S A A = severe aplastic anemia; VZV = varicella zoster virus. Lung function tests: DLCO = single-breath CO-diffusion capacity; FEV1 =forced expiratory volume in I s K C O = K r o g h ' s constant; MBC=maximal breathing capacity; R A W = a i r w a y resistance; RV = residual volume; SRAW = specific airway resistance; TGV =thoracic gas volume; TLC=total lung capacity; VC = vital capacity cells were reduced and the percentage of activated NK cell level lay between 6% and 69%. B-cells were absent or deficient. These findings explain in part the absence of specific antibody reactivity. Five of these patients also contracted GvHD-associated obstructive bronchiolitis, which did not respond to therapy. Pulmonary infiltrates of unknown origin (including idiopathic interstitial pneumonia) occurred in 8 of the patients (11.1%), with a fatal outcome in 3 patients. Significant changes (P < 0.05) in lung function after BMT appeared in the form of reduced vital capacity (VC) increased residual volume (RV) and an increase in RV expressed as the percentage of total lung capacity. Pulmonary diseases were the most common complication and cause of death in our patients after BMT.
Key words: Lung diseases -Bone marrow transplantation -Clinic -Radiology -Histology -Immunology -Lung function Pulmonary complications after bone marrow transplantation (BMT) lead to considerable morbidity and mortality. Along with leukemic relapse [24, 77] and graft-versus-host disease (GvHD) [21] , they represent one of the most common causes of death after BMT [12, 17] . In addition to bacterial pneumonia, infections are often observed which are caused by opportunistic pathogens, viruses, fungi and protozoa [40, 43] . Interstitial idiopathic pneumonia (IP), where the infectious agent cannot be identified with certainty, occur particularly frequently after high radiation doses ( > 8Gy), singledose total-body irradiation and high dosage rates [6, 11, 65] . Adult respiratory distress syndrome (ARDS) [17] and the related capillary leak syn-drome [57] can be caused, among other factors [14] , by sepsis during granulocytopenia, by histoincompatibility between donor and recipient, and by treatment with cyclosporin A. Obstructive bronchiolitis is frequently correlated with chronic GvHD and has not yet been etiologically classified [5, 36, 37, 50] .
This paper presents a study of the clinical, radiological, histological immunological, and functional pulmonary changes in all 72 patients subsequently transplanted in Tfibingen and observed from 9 June 1976 to 31 December J984.
Patients and Methods

Patients
The clinical histories of 72 patients, aged 4-43 (median 17 years), were analyzed. Diagnoses were as follows (for details see Table 2 ): acute myeloid leukemia (AML): 20 patients in complete remission, 2 in partial remission, J in relapse; acute erythroleukemia (AEL): I in complete remission; acute lymphatic leukemia (ALL): 13 in complete remission, 5 in relapse; acute undifferentiated leukemia (AUL): 1 in complete remission and 1 in relapse; chronic myeloid leukemia (CML) in the chronic phase: 10 patients; severe aplastic anemia (SAA): 16 patients; stage IV neuroblastoma: 1 patient in complete and 1 in partial remission. A total of 69 patients received bone marrow from siblings who were completely matched in the HLA-A, B, C, DR system and had negative mixed lymphocyte cultures (MLC). In one instance, the patient's mother fulfilled these prerequisites and served as donor (patient no. 4). One patient (no. 2) received marrow from a donor who was identical only in one haplotype. One neuroblastoma patient (no. 50) received autologous bone marrow that had been cytostatically pretreated ex vivo.
Pretreatment (Conditioning) and Bone Marrow Transplantation (Fig. 1)
Patients with acute leukemia (AL) and CML were treated on 2 consecutive days with 60 mg cyclophosphamide/kg body weight. The neuroblastoma patients (nos. 50, 66) received 30 mg melphalan twice intravenously. After that, 35 of these patients were administered a total-body irradiation of 10 Gy from a linear accelerator at a dose rate of 7 cGy/min (patients l, 3, 4, 7, 8, 10-12, 14, 17-30, 32-35, 37, 38, 42, 44, 45, 47-49) . The lung dose was limited to 8 Gy. Twenty-one patients with leukemia were given a fractionated total-body irradia- anti-human-T-cell globulin [51] tion of 6 x 2 Gy or 5 x 2.5 Gy, with a maximal lung dose of 10 Gy. From patient 38 on, the radiation dose of the ribs was saturated to 10 Gy with supplementary electron irradiation. For immune suppression 15 patients with SAA each received 50 mg cyclophosphamide/kg body weight on 4 consecutive days, followed by a total-body irradiation with 3 Gy in 6 patients, screening the lung completely. One patient (no. 2) was treated intravenously four times with antithymocytoglobulin for immune suppression, whilst the other SAA patients received buffy coat transfusions from their donors after BMT [60] . The bone marrow was filtered to produce a single-cell suspension; it was incubated with anti-human-T-cell-globulin beforehand, if the cell count was above 2 x 108 mononuclear cells/kg [51] . All patients were decontaminated enterally and topically to prevent infections. From the day of transplantation onwards, the patients were isolated for 4-5 weeks in a laminar air-flow unit (reverse isolation) [70] . All patients received cotrimoxazole (30 mg/kg) p.o. as prophylaxis against infections with Pneumocystis carinii. The schedule for conditioning and GvHD prophylaxis can be seen in Fig. 1 . The clinical parameters for diagnosing and grading GvHD follow those described by Storb et al. [60] .
Supportive Therapy
The hemoglobin level was kept above 10.0 g/dl with leukocyte-and ptatelet-poor erythrocyte concentrates and the thrombocyte level over 25,000/gl with thrombocyte concentrates. Granulocyte transfusions were indicated only when there was a documented infection or sepsis with fever over 38.5 ° C and granulocytopenia under 500/gl at the same time, when adequate treatment with antibiotics for at least 24 h failed. Patients 47-72 received 1 ml/kg anti-cytomegalovirus hyperimmune globulin (Cytotect ®, Biotest) every 21 days until the 93rd day after BMT, since a controlled, randomized multicenter study in which we had participated had shown that this results in a significant drop in the incidence of CMV pneumonia [35] . From patient 49 on, 4 x 200 mg acyclovir was given from day -1 0 until day + 100 as prophylaxis against herpes simplex and varicella zoster infections.
X-ray Exam&ations
Radiograms of the lungs were made from two planes at regular intervals before and after BMT. (During reverse isolation they were only made with an anterior-posterior ray path.)
Cultures and Serological Tests
During reverse isolation, bacterial and mycotic cultures were made at regular intervals and whenever clinically indicated. Virus cultures and standard serological tests for viral and fungal infections were only carried out if these pathogens were suspected clinically.
Histological Studies
Biopsy and autopsy material was examined under a light microscope using the following stains: hematoxytin and eosin, elastic-van Gieson, MassonGoldner, PAS and silver impregnation.
Bronchoscopy
If indicated, fiber-optic bronchoscopies were carried out; also, bronchial lavage and transbronchial lung biopsies performed to obtain material for cultures and histological studies.
Lung Function Tests
At irregular intervals before and after BMT and depending on the patient's clinical condition, static and dynamic lung volumes were determined using body plethysmography and diffusion capacity was ascertained. The following parameters were measured with a total-body plethysmograph (Fenyves and Gut, Basel, Switzerland): inspiratory vital capacity (VC); residual volume (RV); thoracic gas volume (TGV); total lung capacity (TLC); RV in % TLC; forced expiratory volume in i s (FEV1); FEV1% VC; maximal breathing capacity (MBC); airway resistance (RAW); specific airway resistance (SRAW); single breath CO-diffusion capacity (DLCO); Krogh's constant (KCO).
Using the normal values of Riihle and Mathys [52] , the measurements are stated as percentages of the predicted values. For technical reasons, only part of the program could be carried out on some patients.
Surface Markers of Mononuclear Blood and Bone-Marrow Cells
The mononuclear cells of heparinized venous blood or bone marrow aspirate were concentrated by density-centrifuging on Ficoll [69] . The following monoclonal antibodies were used to define the cellular subclasses: This diagnosis was based on cultural or histological identification of the pathogen in bronchial secretions, sputum or lung tissue. In some patients, the diagnosis was indicated by the clinical course, for example, by fever, productive cough, dyspnea, rales and the regression of pulmonary infiltrates after treatment with antibiotics [72] .
Fungal Pneumonia (F)
Diagnosis was made after cultural or histological proof of fungus in bronchial secretions or a rise of 2 levels in serum titer and simultaneous clinical and radiological evidence.
Pneumonia Caused by Bacteria and Fungus (BF)
Evidence of (1) and (2) are found simultaneously at the onset of the infection.
Interstitial Viral Pneumonia (V)
This diagnosis was made if viruses could be cultured from lung tissue or if histological changes typical of viruses were found, for example, cytomegalovirus (CMV). A varicella zoster (VZV) pneumonia was diagnosed on the basis of the typical skin rash and a simultaneous rise of more than 2 titer levels.
Pulmonary Infiltrates of Unknown Origin (IP/IF)
If other causes had been ruled out, this diagnosis was made as proposed by Meyers et al. [40] in a large study of 525 patients with nonbacterial and nonfungal pulmonary infiltrates after allogeneic marrow grafting. There were two quite different clinical courses: one (IP) with rapid clinical deterioration within hours, with fever, dry unproductive cough, dyspnea, absence of rales, cyanosis and hypoxia, showing typical interstitial pulmonary infiltrates with homogeneous opacity on the radiogram; and the other (IF) with radiologically documented nonspecific infiltrates only partially correlated with discrete clinical symptoms and never leading to death.
Mycoplasma Pneumonia (M)
Clinical or radiological evidence of pneumonia and a rise of more than 2 titer levels.
Bronchitis (BR)
As in definition 1, but with the infection predominantly affecting the bronchi.
Obstructive Bronchiolitis (O)
This illness is correlated with acute or chronic GvHD [37, 50] and characterized by increasing dyspnea, coughing, cyanosis, pulmonary emphysema, a decrease in VC, FEV1 and DLCO and an increase in RV and SRAW; trapped air is evident.
Histological studies showed a typical bronchiolitis obliterans.
Adult Respiratory Distress Syndrome (A)
This histological designation was chosen for the pulmonary changes in which typical hyaline membranes, interstitial edema and vascular thrombosis were found, although no pathogen could be identified. The typical clinical picture was of increasing dyspnea with the development of global respiratory insufficiency in four phases.
Causes of Death
Several patients contracted more than one of these diseases, such as pneumonia, sepsis, enteritis or GvHD, either simultaneously or in rapid succession. In such instances, the disease which was decisive for the lethal outcome was stated as the cause of death. When GvHD and viral pneumonia occurred together, for example, the pulmonary disease was defned as the cause of death.
Statistical Tests
Four-fold tables were evaluated using the four-fold chi-square test and Fisher's Exact Test. All P values were determined using Fisher's Exact Test. Groups means were compared using Student's ttest with a significance level of 5% for the twosided test.
Results
In 38 (53 %) of 72 transplanted patients, there were 51 episodes of pulmonary complications, leading to death in 20 (28%) patients. Table 1 shows the distribution by diagnosis. In Table 2 , the pulmonary complication, the pathogen, the radiological and histological findings, the cause of death and the intensity of GvHD are given for each patient.
Other causes of death were as follows: 10 leukemia patients died of leukemic relapse, 2 leukemia patients and 1 SAA patient of septic complications during GvHD and 1 SAA patient of an intra-abdominal aneurysmal hemorrhage.
Bacterial Pneumonia (B)
Sixteen bacterial pneumonias were observed in 13 patients with a fatal outcome in 3 patients. The following pathogens were isolated: Pseudomonas aeruginosa (twice), Klebsiella (twice), Proteus (twice), Acinetobacter lwoffi (once), t-hemolytic Streptococci (once), and a mixed flora of Pseudo- monas, Klebsiella and Enterobacter (once). In 7 pneumonias no pathogen could be identified. Three patients died in a very poor general condition during granulocytopenia (nos. 1-3). The typical pneumonic infiltrates were not visible on the radiograms until granulocyte transfusions were given or the patients' own granulocyte production began. In patients 11 and 12, who had contracted a bacterial pneumonia during the primary leukemia therapy long before BMT, the same species of bacteria (P. aeruginosa and Proteus mirabilis, respectively) were isolated as the cause of the pneumonia after BMT.
Fungal Pneumonias (F)
Candida albicans and Torulopsis glabrata were each found once (patients 29 and 34; Fig. 2a ).
Of the four patients suffering from Aspergillus pneumonia, two (nos. 31, 37) died after a fulminant spread of the infection. Another patient (no. 16) died later of a pulmonary hemorrhage in an Aspergillus abscess. There was great variation in the radiographic findings ( Fig. 2b and c) . None of Aspergillus pneumonias could be established histologically before biopsy (patients 16, 21) or autopsy (patients 31, 37) (Fig. 2d) .
Bacterial and Fungal Pneumonias (BF)
In three patients (nos. 4, 5, 14) it had to be assumed that bacteria and fungi were the joint causes of the infection. Only one patient (no. 14) could be treated successfully (see Table 2 ).
Interstitial Viral Pneumonia ( V)
A total of nine viral pneumonias (12.5%) developed, eight of which led to death. Five patients (nos. 12, 28, 33, 38, 44) died of CMV pneumonias, which were all suspected clinically but yielded negative serological tests and could only be proven post mortem either histologically or by culturing viruses. Typical radiological and histological findings are depicted in Fig. 3 a and b . Three patients (nos. 9, 11, 47) contracted a fatal VZV pneumonia following a typical herpes zoster generalisatus. Clinically, all of the patients had high fever, rapidly increasing dyspnea and a slight dry cough. Usually, only a few nonspecific tales and sharper breath sounds could be auscultated. An attempt to treat CMV pneumonia with acyclovir and anti-CMVhyperimmune serum proved as unsuccessful as the attempted treatment of VZV pneumonia (patient no. 11) with c~-interferon. All of the patients but one (no. 47) were administered artificial respiration because of rapidly progressing global respiratory :insufficiency, at the end with Oz concentrations of over 60% and positive respiration pressures of up to 60 cm H20. Four patients (nos. 9, 12, 28, 38) also had an obstructive bronchiolitis (see below page 605), which made mechanical respiration considerably more difficult because lung and cutaneous emphysemas and pneumothorax developed (Fig. 5a) .
Histologically, typical CMV inclusion bodies were found post mortem in pneumonic tissue from another patient who had died of sepsis during GvHD (pat. 25).
Pulmonary Infiltrates of Unknown Orig& (IP/IF)
These kinds of pneumonia were diagnosed in eight (11.1 %) patients, seven with leukemia in remission (nos. 7, 10, 17, 23, 27, 53, 68) and one with neuroblastoma (no. 66). The radiological findings (Fig. 4) showed an increase in interstitial markings distributed over the lung but concentrated in the lower areas. Three of the patients (nos. 10, 23, 68) died of the severe form of this pneumonia. All of the others had the clinically mild form. One further patient (no. I7) developed a fatal adenoviral encephalitis during or after the pneumonia; no histological evidence of interstitial pneumonia could be found post mortem. 
Mycoplasma Pneumonia (M)
One patient (no. 45) developed fever o f up to 41 ° C, cough, slight dyspnea and uncharacteristic p u l m o n a r y infiltrates. The titer rise against mycoplasma led to the diagnosis and treatment with erythromycin proved successful. The patient died 4 months later from the sequelae of an etiologically unclear hemolytic uremic syndrome.
Bronchitis (BR)
F o u r patients (nos. 25, 26, 29, 32) developed acute bronchitis, which might have been one o f the con- (Fig. 6 ). All five patients died of CMV or VZV pneumonias (see above). Histological studies (patients 12, 28, 38, 47) showed extensive obstruction of the lumina of the small bronchi and bronchioles by nonspecific granulation tissue or by fibrous scar tissue (Fig. 5b) . The bronchial and bronchiolar walls were so severely inflamed that they were often barely recognizable as such. The lung tissue was scarred over extensive regions (indurated atelectasis) and was emphysematous in other parts. 
Adult Respiratory Distress Syndrome -ARDS (A)
Two patients (nos. 6 and 50) contracted a highly febrile ( > 40 ° C) pneumonia with rapidly increasing dyspnea during bone marrow aplasia 5 and 13 days after BMT, respectively. The radiograms did not reveal interstitial and alveolar infiltrates until 2-4 days after the onset of the disease. The patients died 2 days and 10 days later, respectively. Histology revealed an interstitial and alveolar edema, hyaline membranes, fibrin thromboses and thrombocyte aggregates in the small vessels. No pathogens could be found. In three other patients (nos. 1-3) who died after bacterial pneumonias during granulocytopenia, the histological diagnosis of ARDS could only be made post mortem, as was also true in one patient (no. 37) with Aspergillus pneumonia and two patients with CMV pneumonia (no. 38, 44).
Correlation with Granulocyte Count
Since the risk of infection increases when the granulocyte count drops below the critical value of 500/gl [45] , we recorded how many bacterial, fungal and ARDS-type pneumonias and bronchitis cases resulted in death with and without granulocytopenia. Of 12 episodes of these complications, 8 resulted in death with granulocyte levels under 500/pl, but only 1 of 18 when the granulocyte count was above 500/@ (significant difference, P = 0.002).
Correlation Between Primary Disease and Pulmonary Complication
The risk of viral interstitial pneumonia in patients surviving more than t4 days was 8:43 with leukemia and 1:13 with SAA ( P = 0.75, not significant). The probability of these patients developing an idiopathic interstitial pneumonia was 6:45 with leukemia and 0:14 with SAA (no significant difference ; P = 0.44). There was no correlation between smoking or drinking alcohol and the occurrence of certain lung diseases.
Correlation with Graft-versus Host Disease
Only the 60 patients who were at risk of developing GvHD were taken into account. Therefore, the 12 patients without bone marrow take and those undergoing syngeneic or autologous BMT were excluded, as well as those who died within 14 days after BMT. None of the 35 patients without severe acute ( > I °) or chronic GvHD contracted a virus pneumonia. In contrast, there were 9 viral pneumonias among the 24 patients with acute GvHD II-IV ° or chronic GvHD (P<0.001, significant difference). Obstructive bronchiolitis was likewise observed only with acute GvHD I~I V ° or chronic GvHD. There was no positive or negative correlation between bacterial, fungal, mixed pneumonia or pneumonia of unknown origin and GvHD.
Nine patients suffered two or more episodes of pulmonary complications each (patients 5, 9, 11, 12, 25, 28, 29, 38, 47) . Only one of them (no. 
Time Dependence of Pulmonary Complications after B M T
After a peak in the first 4-8 weeks, the frequency of pulmonary complications decreased (Fig. 7) , but pneumonias were observed as long as 58 weeks after BMT (Table2). Such an incidence has changed increasingly as a result of more rigorous patient selection, fractionated radiation therapy and the use of cyclosporin A instead of methotrexate, so that fatal pneumonias in the first 4 weeks are now rare. In two patients (nos. 63, 65), chronic bronchitis must be assumed to be the cause of the pneumonia.
Lung Function Tests
We were able to examine 26 patients after BMT.
The test results are shown in Fig. 8 for the period before BMT and the period from 1-6 months after BMT.
Vital capacity (VC) and Krogh's constant (KCO) were below the normal range even before BMT, while residual volume (RV), RV % total lung capacity (TLC) and specific airway resistance (SRAW) were elevated.
After BMT there were significant changes: VC was lower and RV higher, as was RV % TLC. The other parameters examined did not change significantly.
Profile of the Surface Markers on Mononuclear Blood and Bone-Marrow Cells
In Fig. 9 the distribution of mononuclear cells that were identified with monoclonal antibodies is shown. Patients 9, 11 and 47 had a VZV pneumonia; the others had CMV pneumonia. In five evaluable cases the number of helper/inducer T cells in the blood was reduced, while the number of suppressor T cells was raised (patients 12, 25, 28, 38, 44) . Similar results were obtained from the bone marrow (patients 25, 28, 38) . The autoreactivity-controlling T-cells in the blood were reduced (patients 12, 25, 44) . Except in patient no. 44, the number of NK cells lay below the normal range. Activated NK cells were low in the blood of five patients (nos. 12, 25, 28, 44, 47) . In five of the patients examined no B-cells could be detected in the blood (nos. 9, 11, 25, 33, 44) and in another only 2% (patient no. 47).
All of these patients had acute or chronic GvHD at the time of marker determination and of pneumonia.
Discussion
Gram-negative bacteria were the primary cause of pneumonias during granulocytopenia in the early post-transplant period. Patients who were transplanted in advanced leukemic relapse or, with SAA, in a poor general condition all died of pneumonia [70] . Granulocytopenia meant a significantly higher risk of death for patients who contracted bacterial or mycotic pneumonia or ARDS during this phase. The poor results and the similar experience of other centers [61] were among the reasons that prompted us to carry out BMT for leukemia only on patients in complete remission and in a good physical condition [10, 62] . After this, there were no more cases of early death from bacterial pneumonia, results which correspond with the observations of Winston et al. [74] . Other important factors were the early administration of broadspectrum antibiotic combination therapy [62, 74] to patients with temperatures over 38.5 ° C, as well The mycotic pneumonias could be diagnosed by culturing after bronchioalveolar lavage, but never on the basis of the radiograms (see Figs. 2 a  and 4) . The massive mycotic colonization of the gastrointestinal tract of these patients suggests that enterogenic sepsis was the cause of these fungal pneumonias. Both patients were treated successfully with a combination of amphotericin B (0.3 mg/kg per day) and 5-fluorocytosine (150 mg/kg per day) [38] . In three other patients, a simultaneous pulmonary infection with C. albicans and bacteria had to be treated with antibiotics as well.
Two different courses were taken by two Aspergillus pneumonias, each depending on whether they appeared during or after granulocytopenia. Without granulocytes homogenous, opaque infiltrates appeared on the radiograms and spread over both lungs within 1-2 days. Both patients died soon afterwards. The two Aspergillus pneumonias that ap-peared when the granulocyte levels were normal began as soft, spotty infiltrates, which slowly increased in size, and some of these infiltrates developed into pulmonary cavities. The antimycotic therapy described caused the infiltrates to recede and led to the absence of clinical symptoms in both of these patients. It was only possible to diagnose these four patients histologically, in two cases after transbronchial lung biopsies and in two cases after post-mortem examination. In none of these patients was it possible to find the initial focus. Other centers have had similar experiences [67, 72] . Because the paranasal sinuses are suspected to be the initial focus, Watson [67] recommended irrigation before BMT whenever the sinuses display radiological abnormalities. The bad prognosis with Aspergillus pneumonia makes prompt antimycotic therapy with amphotericin B advisable whenever lung infiltrates continue to increase despite treatment with antibiotics. Furthermore, we emphasize the need for fiber-optic bronchoscopy with bronchial lavage and transbronchial lung biopsies in these patients. A marked reduction in invasive Aspergitlus infections can be attained by using filtered air with HEPA recirculation filters in sickrooms [67] . We did use these, but our patients stayed at most 6 weeks in the laminar air-flow system with filtered air.
Interstitial pneumonias from cytomegalo-or varicella zoster viruses appeared only with acute GvHD II-IV ° or chronic GvHD a n d led to death in eight of nine patients in our patient group. Other centers report similar results, with 60%-90% mortality after CMV pneumonia [40, 67] as well as a higher risk for older patients. The pathogenesis of CMV pneumonia after BMT, which can appear in a miliary and a diffuse form [8] , is the subject of controversy. The first form might result from hematogenous dissemination into the lung from an extrapulmonary source; the second form possibly develops from the gradual spread or the activation of an endogenous intrapulmonary virus [8] . Our histological and clinical findings fit better with the miliary form, although in some patients only a few of the typical owl's-eye cells were present.
It is generally believed that CMV-infected patients usually succumb to their infections after BMT if they are not able to develop CMV-specific cytotoxicity, but only a nonspecific, natural and antibody-dependent cytotoxicity [46] . Like the GvHD reaction [3, 23, 27] , CMV infections cause a reversal of the ratio of helper (OKT 4 +) to suppressor (OKT 8 +) T-cells, with an absolute decline in the number of helper T-cells. In all of our patients with CMV or VZV pneumonia, this reversed ratio was likewise present, with a marked reduction of helper cells. The NK cells or their precursors (Leu 7 +) were reduced in five patients. Activated NK cells (HLA-DP+/DR +) in the blood made up 6%-48%, whereas B-cells were absent or extremely reduced in six patients. This considerable drop in helper cells noted in our cases prevented a specific immune response to viral antigens. Besides, NK cells or their precursors differentiated only partially to activated T-cells, as assessed on the basis of their HLA-DR/DP positivity. It is conceivable that this differentiation defect stems from the absence of the interleukin 2 normally produced in sufficient quantities by the helper cells [68] , which are reduced here. In addition, a humoral immune response was not possible in several patients because of the absence of B-cells. This impaired immune regulation could be caused by the suppressive effect of the GvHD present in all of the patients [3, 22, 53] , by the GvHD therapy often carried out, or by the virus infection itself [30, 33, 39, 53, 64] , all conditions allowing the diseases to spread rapidly and lead to death.
CMV viruses can be transmitted by blood transfusions; the leukocytes are probably the source of the infection. Thus, fewer CMV infections occurred after BMT if CMV-seronegative recipients were not given granulocyte transfusions [28, 42] . Since no means of successfully treating CMV infections exist at present [41, 66, 75] , the effective prophylaxis provided by anti-CMV hyperimmune globulin becomes all the more important [19, 34, 42, 71, 75] . In our own experience, CMV pneumonias can be prevented for as long as prophylactic measures are being taken. However, some questions remain to be answered. Which minimum globulin dose is sufficient in view of the high costs? Should patients with GvHD be treated beyond day 1007 One of our patients with GvHD, for example, contracted a CMV pneumonia only when anti-CMV prophylaxis was stopped [35] .
One patient with VZV pneumonia was treated unsuccessfully with acyclovir, although theoretically that substance should have been effective [25] . On the other hand, once we began to administer oral acyclovir prophylactically, no more VZV infections were observed during the therapy phase.
Only 11.1% of our patients contracted pneumonia of unknown etiology, which includes idiopathic interstitial pneumonia. Unfortunately, the diagnosis was not confirmed histologically. Other centers have reported an incidence of interstial pneumonia of 10% (Royal Marsden, London) [7] , 11%-13%-20% (Seattle) [1, 40, 43] , or 20% (In-ternational Bone Marrow Transplant Registry, Los Angeles) [11, 72] . The etiology of idiopathic interstitial pneumonia is still unknown, but there is a statistically significant correlation with totalbody irradiation [6, 11, 26, 32, 40, 49, 56, 63, 65] .
In our experience, none of the patients with SAA contracted interstitial pneumonia, indicating a direct causal link with radiation therapy, because in contrast to the leukemia patients, none of the SAA patients received lung irradiation. The Seattle group has also published similar findings [1, 40] . In addition, the earlier cytostatic therapy for leukemia could damage the lungs severely [18] and encourage the development of idiopathic interstitial pneumonia after total-body irradiation. The reason for our low incidence of IP is very likely the low irradiation dose rate (7 cGy/min) [7, 11, 49, 63] , the restriction of the lung dose to 8 Gy with single-dose or 10 Gy with fractionated total-body irradiation [6, 32, 56, 63] and the use of fractionated irradiation [26, 56, 65] .
In contrast to other reports [40] we found no correlation between pneumonia of unknown etiology and GvHD.
ARDS, which was the only pulmonary complication in two of our patients and which was diagnosed in six others in addition to pnemnonia, can be produced by sepsis, viral lung infections and shock, among many other factors [14, 48] . In all of our patients, on the basis of the clinical course we must assume that an infection was the cause. The pathogenesis of ARDS after BMT is still unclear [14] . It is conceivable that it is encouraged by endothelial damage to the pulmonary vessels from total-body irradiation [59, 73] and the activation of complement by granulocyte transfusions [31] . Radiograms sometimes showed diffuse, opaque infiltrates, but more often revealed spotty, relatively well-defined infiltrates of varying intensity. A correlation of ARDS with cyclosporin A therapy [57] was not observed in our patients, thus supporting the report of Braude et al. [14] .
Since we [37] and Roca et al. [50] first reported on obstructive bronchiolitis during chronic GvHD, several centers have confirmed our observations [5, 13, 29, 36, 47] . These findings agreed regarding a correlation with chronic GvHD, the gradual clinical onset with dyspnea on exertion and with coughing, the decrease in vital capacity and increase in residual volume, airway obstruction, increasing emphysema and recurrent pneumothorax and, in the advanced stage, cutaneous or mediastinal emphysemas. Histological studies similarly revealed fibrosis and a patchy scattering of bronchiolitis obliterans with peribronchial infiltrates, but no lymphocytic bronchitis [13] . Other authors have described a distal, mixed inflammatory reaction and fibrosis, diffuse alveolar damage with exudative and organizing components, intra-alveolar fibrin deposits and isolated hyaline membranes in some patients, and lymphocytic infiltrates around the terminal bronchiolus with necroses of the bronchiolar epithelium in others [29, 47] . In further reports, one can read of a reduction in the number of alveolar sacs, bronchioli filled with macrophages, focal obliteration of the bronchiolar walls, atelectasis, emphysema, and interstitial fibrosis, but there is no evidence concerning lymphocytic bronchitis or bronchiolitis [36, 50] . The presence of lymphocytic infiltrates is important because Beschorner et al. [8] have interpreted them as evidence of acute bronchial GvHD, although this has been contradicted [44] and the infiltrates have instead been viewed as a nonspecific inflammatory reaction. There was no sign of lymphocytic bronchitis in our five patients. It is unclear what role GvHD plays in the pathogenesis of obstructive bronchiolitis, but the fact that it only appears during GvHD, and chiefly only in its chronic form, suggests a causal involvement. The following factors are held to be ultimately responsible: a low IgA level with a subsequent lack of mucous membrane protection by the secretory immune system, damage to the mucociliary apparatus by the GvHD-associated Sicca syndrome [54] , and a general reduction in the humoral and cellular immune reaction [47, 76] . Therapy with prednisolone did not improve the condition of the three patients with the most severe clinical symptoms, nor did the use of spasmolytics, bronchodilators, mucolytics or antibiotics. Other authors have reported marked subjective and (sometimes) objective improvement, especially when prednisolone was administered as soon as the first symptoms appeared [29, 47] . Thus, it is advisable to monitor lung function in GvHD patients regularly and, if necessary, to begin prednisolone therapy at the first sign of a bronchiolar obstruction.
Lung function tests after BMT revealed a significant incidence of pulmonary hyperinflation and reduction in vital capacity. In contrast to other authors [17, 55] , we found an increase rather than a reduction in RV and TLC and no restrictive changes. To date there is no explanation for these findings. Diffusion capacity dropped in our patients somewhat, but not significantly, in contrast to other studies [20, 58] . However, if only the leukemia patients are considered, as in the two studies just cited, then the DLCO reduction in our patients was also statistically significant (data not shown).
Whether this difference is due to the antileukemic chemotherapy given beforehand or primarily to the total-body irradiation of leukemia patients is not yet clear [17, 55] .
Pulmonary diseases represent the most important complication and the most common cause of death after BMT in our patients. Some of the predisposing factors are known and must be combated with intensive prophylactic measures, because the therapeutic possibilities are often limited. The prevention of chronic GvHD, which is almost always the basis for viral pneumonias, obstructive bronchiolitis and recurring pneumonias, is of vital importance. Bacterial pneumonias can be reduced by shortening the duration of granulocytopenia and fungal pneumonias by painstaking prevention of exposure and accurate diagnosis. It is possible to reduce the risk of idiopathic interstitial pneumonia by adjusting radiation techniques, but efforts should be directed toward lessening its frequency even further because of the high mortality rate.
